Comparison of Microscopy and First Response™ Malaria Antigen Tests in Kenya

Overview

This study evaluates the diagnostic performance of microscopy and rapid diagnostic tests (mRDTs) for malaria in pregnant women during delivery in Busia County, Kenya, compared to qPCR. It also assesses the prevalence of malaria in pregnancy and its association with maternal hemoglobin levels and ABO blood group.

Background

Malaria in pregnancy (MiP) poses significant health risks, contributing to maternal and infant morbidity and mortality. The World Health Organization recommends universal diagnosis and treatment of malaria, yet challenges remain in accurately diagnosing MiP due to low parasite densities and limitations of current diagnostic tools. Understanding the diagnostic performance of available methods is crucial for improving maternal health outcomes in endemic regions.

Data Highlights

No numerical data available in the source material.

Key Findings

• Microscopy and mRDTs are primary diagnostic tools recommended by WHO for detecting malaria in pregnant women.
• Microscopy often fails to detect low levels of parasites, particularly in placental malaria cases.
• mRDTs can yield false-positive results due to antigen persistence after treatment.
• Quantitative PCR (qPCR) offers a more sensitive method for detecting P. falciparum but is resource-intensive.
• ABO blood group may influence susceptibility to malaria and associated anaemia, though findings are inconsistent.
• Malaria accounts for approximately 25% of severe anaemia in pregnant women in endemic areas.

Clinical Implications

Healthcare providers should be aware of the limitations of microscopy and mRDTs in diagnosing malaria in pregnancy, particularly in low-resource settings. Enhanced diagnostic strategies, including qPCR, may be necessary for accurate detection and management of MiP.

Conclusion

The study highlights the need for improved diagnostic methods for malaria in pregnancy to enhance maternal and infant health outcomes in endemic regions.

Related Resources & Content

1. World Health Organization, WHO Malaria Report, 2024 -- Global guidance and diagnostic standards
2. Infection, 2020 -- Assessment of Plasma Parasitemia via Quantitative PCR and Its Correlation with Clinical Severity in African Adults Suffering from Falciparum Malaria, With and Without HIV Co-Infection
3. Infection, 2024 -- Assessment of a Dual-Antigen CRP Rapid Diagnostic Test for Plasmodium in Lambaréné, Gabon
4. The Journal of Infectious Diseases -- High Incidence of False-Positive Results in Malaria Rapid Diagnostic Tests Among Ugandan Children Under Five
5. Open Forum Infectious Diseases -- Impact of Antimalarial Drug Selection for Pregnancy on Infant Immune Responses to Plasmodium falciparum Erythrocyte Membrane Proteins 1